Latest advances in the regulatory genes of adipocyte thermogenesis

✅ 全文

脂肪细胞产热调控基因的最新进展

作者 Tao Nie; Jinli Lu; Hua Zhang; Liufeng Mao 期刊 Frontiers in Endocrinology 发表日期 2023 ISSN 1664-2392 DOI 10.3389/fendo.2023.1250487 类型 原创研究 (Original Research)

📄 英文摘要 English Abstract

EN

An energy imbalance cause obesity: more energy intake or less energy expenditure, or both. Obesity could be the origin of many metabolic disorders, such as type 2 diabetes and cardiovascular disease. UCP1 (uncoupling protein1), which is highly and exclusively expressed in the thermogenic adipocytes, including beige and brown adipocytes, can dissipate proton motive force into heat without producing ATP to increase energy expenditure. It is an attractive strategy to combat obesity and its related metabolic disorders by increasing non-shivering adipocyte thermogenesis. Adipocyte thermogenesis has recently been reported to be regulated by several new genes. This work provided novel and potential targets to activate adipocyte thermogenesis and resist obesity, such as secreted proteins ADISSP and EMC10, enzyme SSU72, etc. In this review, we have summarized the latest research on adipocyte thermogenesis regulation to shed more light on this topic.

📄 中文摘要 Chinese Abstract

中文
能量失衡导致肥胖:能量摄入过多或能量消耗过少,或两者兼有。肥胖可能是许多代谢紊乱的根源,如2型糖尿病和心血管疾病。UCP1(解偶联蛋白1)在产热脂肪细胞(包括米色和棕色脂肪细胞)中高度且特异性表达,可将质子动力势转化为热量而不产生ATP,从而增加能量消耗。通过增加非颤抖性脂肪细胞产热来对抗肥胖及其相关代谢紊乱是一种有前景的策略。近期研究发现脂肪细胞产热受多个新基因的调控。本工作为激活脂肪细胞产热和抵抗肥胖提供了新的潜在靶点,如分泌蛋白ADISSP和EMC10、酶SSU72等。本文综述了脂肪细胞产热调控的最新研究进展,以期为该领域提供更多见解。

📋 英文结构化总结 English Structured Summary

全文整理

EN

Background:

An energy imbalance cause obesity: more energy intake or less energy expenditure, or both. Obesity could be the origin of many metabolic disorders, such as type 2 diabetes and cardiovascular disease. UCP1 (uncoupling protein1), which is highly and exclusively expressed in the thermogenic adipocytes, including beige and brown adipocytes, can dissipate proton motive force into heat without producing ATP to increase energy expenditure. It is an attractive strategy to combat obesity and its related metabolic disorders by increasing non-shivering adipocyte thermogenesis. Adipocyte thermogenesis has recently been reported to be regulated by several new genes. This work provided novel and potential targets to activate adipocyte thermogenesis and resist obesity, such as secreted proteins ADISSP and EMC10, enzyme SSU72, etc. In this review, we have summarized the latest research on adipocyte thermogenesis regulation to shed more light on this topic.

Methods:

N/A - Review article

Results:

Key findings include the identification of secreted proteins EMC10 and ADISSP as regulators of adipocyte thermogenesis. For EMC10, secreted EMC10 (scEMC10) serum contents in human populations were positively correlated with obesity and insulin resistance; whole-body Emc10 knockout mice displayed more adipocyte thermogenesis and higher whole-body energy expenditure and resisted obesity, while Emc10 overexpression mice had less adipocyte thermogenesis and lower whole-body energy expenditure. Mechanistically, secreted EMC10 interacts with the Protein Kinase A catalytic subunit a to inhibit it from phosphorylating CREB, reducing thermogenesis. ADISSP (Adipose secreted signaling protein) is a new uncharacterized adipokine highly and selectively expressed in brown adipose tissue in humans and mice, with expression higher in adipose tissue of normal people than obese people and negatively correlated with body weight index.

Data Summary:

Serum scEMC10 levels were positively correlated with obesity and insulin resistance in white and Chinese Han populations; levels decreased after bariatric surgery or exercise and caloric restriction. Emc10 knockout mice on high-fat diets resisted obesity and insulin resistance with increased adipocyte thermogenesis and energy expenditure, while Emc10 overexpression mice were more easily induced into obesity with reduced thermogenesis. ADISSP expression is higher in normal people than in obese people and is negatively correlated with body weight index.

Conclusions:

This work provided novel and potential targets to activate adipocyte thermogenesis and resist obesity, such as secreted proteins ADISSP and EMC10. Activating thermogenic adipocytes is a promising strategy to combat obesity.

Practical Significance:

Real-world applications include the use of circulating neutralizing antibody to EMC10, which helped mice reduce body weight gain, suggesting potential therapeutic targeting of these secreted proteins for obesity treatment. Increasing non-shivering adipocyte thermogenesis is an attractive strategy to combat obesity and its related metabolic disorders.

📋 中文结构化总结 Chinese Structured Summary

中文

背景:

能量失衡导致肥胖:能量摄入过多或能量消耗过少,或两者兼有。肥胖可能是许多代谢紊乱的根源,如2型糖尿病和心血管疾病。UCP1(解偶联蛋白1)在产热脂肪细胞(包括米色和棕色脂肪细胞)中高度且特异性表达,可将质子动力势转化为热量而不产生ATP,从而增加能量消耗。通过增加非颤抖性脂肪细胞产热来对抗肥胖及其相关代谢紊乱是一种有前景的策略。近期研究发现脂肪细胞产热受多个新基因的调控。本工作为激活脂肪细胞产热和抵抗肥胖提供了新的潜在靶点,如分泌蛋白ADISSP和EMC10、酶SSU72等。本文综述了脂肪细胞产热调控的最新研究进展,以期为该领域提供更多见解。

方法:

不适用——综述类文章

结果:

主要发现包括鉴定出分泌蛋白EMC10和ADISSP是脂肪细胞产热的调控因子。对于EMC10,在人群中,分泌型EMC10(scEMC10)血清含量与肥胖和胰岛素抵抗呈正相关;全身Emc10基因敲除小鼠表现出更强的脂肪细胞产热和更高的全身能量消耗,并能抵抗肥胖,而Emc10过表达小鼠的脂肪细胞产热减弱、全身能量消耗降低。机制上,分泌型EMC10与蛋白激酶A催化亚基α相互作用,抑制其对CREB的磷酸化,从而降低产热。ADISSP(脂肪分泌信号蛋白)是一种新的未充分表征的脂肪因子,在人和小鼠棕色脂肪组织中高度选择性表达,正常人群脂肪组织中的表达高于肥胖人群,且与体重指数呈负相关。

数据总结:

在白种人和中国汉族人群中,血清scEMC10水平与肥胖和胰岛素抵抗呈正相关;在减重手术或运动及热量限制后水平下降。高脂饮食条件下,Emc10基因敲除小鼠抵抗肥胖和胰岛素抵抗,脂肪细胞产热和能量消耗增加,而Emc10过表达小鼠更容易被诱导肥胖,产热降低。ADISSP在正常人群中的表达高于肥胖人群,且与体重指数呈负相关。

结论:

本工作为激活脂肪细胞产热和抵抗肥胖提供了新的潜在靶点,如分泌蛋白ADISSP和EMC10。激活产热脂肪细胞是对抗肥胖的有前景的策略。

实际意义:

实际应用包括使用循环中和抗体靶向EMC10,该抗体帮助小鼠减少体重增加,提示靶向这些分泌蛋白可能具有治疗肥胖的潜力。增加非颤抖性脂肪细胞产热是对抗肥胖及其相关代谢紊乱的有前景的策略。

📖 英文全文 English Full Text

EN

TYPE Review PUBLISHED 23 August 2023 DOI 10.3389/fendo.2023.1250487 OPEN ACCESS EDITED BY Claire Joanne Stocker, Aston University, United Kingdom REVIEWED BY

Antonia Lanni, University of Campania Luigi Vanvitelli, Italy José Marı´a Moreno-Navarrete, CIBER Fisiopatologı´a Obesidad y Nutrición (CIBEROBN), Spain

Latest advances in the regulatory genes of adipocyte thermogenesis Tao Nie 1*, Jinli Lu 2, Hua Zhang 3* and Liufeng Mao 2* 1 School of Basic Medicine, Hubei University of Arts and Science, Xiangyang, China, 2 Scientific Research Center, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China, 3 Department of Medical Iconography, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China

*CORRESPONDENCE

Tao Nie nie_tao@hbuas.edu.cn Hua Zhang 664797047@qq.com Liufeng Mao mlf_9295@126.com RECEIVED 30 June 2023 ACCEPTED 07 August 2023 PUBLISHED 23 August 2023 CITATION

Nie T, Lu J, Zhang H and Mao L (2023) Latest advances in the regulatory genes of adipocyte thermogenesis. Front. Endocrinol. 14:1250487. doi: 10.3389/fendo.2023.1250487 COPYRIGHT

© 2023 Nie, Lu, Zhang and Mao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

An energy imbalance cause obesity: more energy intake or less energy expenditure, or both. Obesity could be the origin of many metabolic disorders, such as type 2 diabetes and cardiovascular disease. UCP1 (uncoupling protein1), which is highly and exclusively expressed in the thermogenic adipocytes, including beige and brown adipocytes, can dissipate proton motive force into heat without producing ATP to increase energy expenditure. It is an attractive strategy to combat obesity and its related metabolic disorders by increasing nonshivering adipocyte thermogenesis. Adipocyte thermogenesis has recently been reported to be regulated by several new genes. This work provided novel and potential targets to activate adipocyte thermogenesis and resist obesity, such as secreted proteins ADISSP and EMC10, enzyme SSU72, etc. In this review, we have summarized the latest research on adipocyte thermogenesis regulation to shed more light on this topic. KEYWORDS

obesity, adipocyte thermogenesis, adrenergic signaling pathway, PKA, UCP1

1 Introduction Obesity is becoming more and more prevalent all over the world and is a huge risk to human health (1). An energy imbalance causes obesity: more energy intake or less energy expenditure, or both. So it is effective to prevent and treat obesity by reducing energy intake or increasing energy expenditure. GLP-1 has been clinically used to treat obesity effectively by decreasing energy intake (2, 3). In these years, lots of studies have reported that nonshivering adipocyte thermogenesis, which always maintains the body temperature, can be promoted to increase energy expenditure and resist obesity. It is a promising strategy to combat obesity by activating the thermogenic adipocytes (4, 5). Adipose tissue is classically divided into white adipose tissue (WAT) and brown adipose tissue (BAT). Morphologically, white adipocyte has a unique large lipid droplet, while brown adipocyte has many small lipid droplets and more functional mitochondria (6). Functionally, white adipocyte stores energy and secrets many cytokines, including adiponectin and leptin et ac., to regulate metabolism (7); brown adipocyte highly express a

transcriptional factors, kinases, and membrane receptors, like FGF21, IRF4, and ZFP516 et al., are involved in adipocyte thermogenesis (28–31). Here, we have summarized the latest studies involved in adipocyte thermogenesis listed in Table 1 and Figure 2.

mitochondrial inner membrane protein UCP1 (Uncoupling protein 1), which can dissipate proton motive force into heat without producing ATP. Under cold or pharmacological conditions, a brown-like adipocyte called a beige adipocyte or brite adipocyte, is induced in white adipose tissue (8). Like brown adipocyte, beige adipocyte have many small lipid droplets and highly expressed UCP1 to produce heat; brown and beige adipocytes are also called thermogenic adipocytes (Figure 1). Brown and beige adipocytes are functionally the same, but their origins differ. Beige and white adipocytes are mostly Myf5 negative (9–11), while brown adipocytes are Myf5 positive and share a precursor cell with myocyte (12). Prdm16 is the master gene for brown and beige adipocyte identity. Overexpression of Prdm16 in myoblast can trans-differentiate it into brown adipocyte (13, 14), and the knockout of Prdm16 in white adipocyte tissue abolished the induction of beige adipocyte by cold (15, 16). Interestingly, when the beta-adrenergic signaling pathway was ablated in white adipose tissue, a kind of glycolytic beige adipocyte was induced from Myf5 positive precursor cells (17). Brown adipose tissue is located in the interscapular depot in mammals, and white adipose tissue is mainly located in the subcutaneous and visceral depot (6). It is noted that brown adipose tissue gradually disappeared when humans grew up (18, 19). There are brown and beige adipocytes in the deep human neck (20, 21). In addition, beige and brown adipocytes positively correlate with body weight (22, 23). Cold exposure is the most effective way to stimulate adipocyte thermogenesis. Upon cold exposure, adipose tissue was sympathetically innervated. The secreted norepinephrine binds with a beta-adrenergic receptor in adipocytes and activates the Gs signaling pathway and adenylyl cyclase to elevate the cycle adenosine (cAMP) contents. And then, cAMP binds with the regulatory subunit of protein kinase A (PKA) to activate its catalytic subunit C to phosphorylate the following transcriptional factor CREB. The phosphorylated protein CREB enters the nucleus and upregulates thermogenic genes, including Ucp1 et al. (24–27). Many studies have reported that many kinds of cytokines,

2 Factors directly act on adipocyte 2.1 Secreted proteins 2.1.1 EMC10 Due to differential splicing, endoplasmic reticulum membrane complex subunit 10 has two isoforms: membrane EMC10 and secreted EMC10 (scEMC10) (45, 46). ScEMC10 serum contents in white and Chinese Han human populations were positively correlated with obesity and insulin resistance. After bariatric surgery or exercise and caloric restriction, serum scEMC10 levels decreased. The whole-body Emc10 knockout mice, displaying more adipocyte thermogenesis and higher whole-body energy expenditure, resisted obesity and insulin resistance induced by high-fat diets. Conversely, Emc10 overexpression mice were more easily induced into obesity and insulin resistance on high-fat diets, had less adipocyte thermogenesis, and lower whole-body energy expenditure. In addition, the circulating neutralizing antibody to EMC10 also helped mice to reduce body weight gain. Mechanically, secreted EMC10 can be taken up by adipocytes and interacted with the Protein Kinase A catalytic subunit a to inhibit it from phosphorylating CREB. So the decreased phosphorylated CREB proteins led to a reduction in adipocyte thermogenesis (47).

2.1.2 ADISSP ADISSP (Adipose secreted signaling protein) is a new uncharacterized adipokine, highly and selectively expressed in brown adipose tissue in humans and mice. The expression of this protein is higher in adipose tissue in normal people than in obese people and is negatively correlated with body weight index. The

FIGURE 1

Three types of adipocytes: white adipocyte, beige adipocyte, and brown adipocyte. Beige adipocyte and brown adipocytes are thermogenic adipocytes for non-shivering thermogenesis. Frontiers in Endocrinology

02 frontiersin.org Nie et al. 10.3389/fendo.2023.1250487 TABLE 1 Genes involved in adipocyte thermogenesis. Genotype Targeted tissue Adipose thermogeneis Diet Metabolic symptom Potential mechanism Human study

Reference Emc10-/- Whole body Up High fat diet Decrease body weight and improve insulin sensitivity Interact with PKA Ca to block its activity Yes 47 Adissp Adipose tissue Up High fat diet Decrease body weight, increase glycolysis and imporve glucose homeostasis

Activate PKA independent on adrenergic signaling pathway Yes 32 Hif2a-/- Adipose tissue Up Standard chow diet Enhance white adipose browing upon cold exposeure Increase the expression of PKA Ca None 33

Ovol2boh/boh Whole body Down Standard chow diet Increase body weight, cold intolerant and insulisn resistance Interact with CEBPa to inhibit adipogenesis Yes 34 Tmem86a-/- Adipose tissue Up High fat diet

Decrease body weight, attenuate inflammation and improve insulin sensitivity Increase cAMP contents None 35 Ssu72-/- Adipose tissue Down Standard chow diet Dysfucntion of mitochondira and cold intolerance

Inhibit the phosphorylation of eIF2a Yes 36 Cul2-/or Appbp2-/- Adipose tissue Up High fat diet Counteracts diet-induced obesity, insulin resistance and dyslipidaemia CUL2–APPBP2 catalyses the polyubiquitinatio of PRDM16 protein and decreased its half life

Yes 37 Gpr180-/- Whole body Down High fat diet Increase body weight and insulin resistance Component of TGFb signaling pathway Yes 38 Ncc-/- Adipose tissue Down High fat diet Increase body weight and insulin resistance

Mediate IL-18 function Yes 39 Opa1Tg Whole body Up High fat diet Decrease body weight, resist cold and improve insulin sensitivity Activate CREB Yes 40 Mcu1-/Emre-/- Adipose tissue Down High fat diet Increase body weight and decrease body temperature

Form thermoporter with UCP1 Yes 41 UCP1 C253A Adipose tissue Down High-fat, highsucrose diet Cold intolerance, more inflammation in male mice Increase mitochondria ROS None 42 ACE2Tg Whole body Up Standard chow diet

More theromogenci adipocyte and less adipose tissue weight Promote the expression of VEGF Yes 43 Mt2-/- Adipose tissue Up High fat diet Increase sympathetic innervation and energy expenditure Promote sympathetic neuron induced thermogenesis

Yes 44 Tg be activated independently of the beta-adrenergic signaling pathway by ADISSP (32). Though a surface receptor in adipocytes binds to ADISSP, the receptor gene is still not confirmed and unknown.

overexpression of Adissp in adipose tissue by Ap2 promoter-driven promoted adipocyte thermogenesis, augmented oxygen consumption, increased glycolysis, elevated body temperature, and resisted body weight gain induced by high-fat diets. In contrast, adipose-specific Adissp knockout mice had lower body temperature, less adipocyte thermogenesis, and were more susceptible to high-fat diet-induced obesity and hyperglycemia. ADISSP promoted white adipocyte browning and brown adipocyte activity by paracrine signaling but not by endocrine signaling. A more sensitive assay is lacking to measure ADISSP endogenous circulating contents. The PKA signaling pathway can

2.2 Transcriptional factors 2.2.1 HIFa HIFa (Hypoxia-inducible factor a, HIFa) has two family members: HIF1a and HIF2a (48). These two genes were upregulated in white and brown adipose tissue after cold exposure.

03 frontiersin.org Nie et al. 10.3389/fendo.2023.1250487 FIGURE 2

A schematic picture illustrates the latest studies on adipocyte thermogenesis regulation. The green color stands for the positive regulators, and the brown color stands for the negative ones.

The adipose Hif1a, or Hif2a, or double-specific knockout mice had more beige adipocytes in the inguinal adipose tissue and higher energy expenditure compared to the wild-type mice upon cold exposure or CL316243 (beta-adrenergic agonist) stimulation. By RNA-Seq analysis, Prkaca, which encodes PKA catalytic subunit a (PKA Ca), was a highly ranked gene in adipose tissue of Hif2a knockout mice. Using in silico analysis, miR-3085-3p, directly regulated by HIF2a, was identified to target the evolutionarily conserved region of 3’ UTR of Prkaca. So, adipocyte HIF2a could suppress PKA Ca-mediated thermogenic properties by promoting miR-3085-3p expression (33).

2.3 Enzyme 2.3.1 TMEM86A Transmembrane protein 86A (TMEM86A) is a putative lysoplasmalogenase, a close homolog of TMEM86B, and a YhhN family protein member (50, 51). Tmem86a expression was significantly upregulated in adipose tissue on high-fat diets compared to the standard chow diet and heavily enriched in mature adipocytes. Transcriptome-profiling (GEO: GSE94753) also shows that TMEM86A expression is upregulated in abdominal subcutaneous WAT from female patients with obesity compared to individuals without obesity. The adipose tissue-specific Tmem86a knockout mice had increased mitochondrial metabolism, adipocyte thermogenesis, and energy expenditure and exhibited significantly lower body weight gain. Mechanistically, the untargeted lipidomics analysis suggested that Tmem86a overexpression downregulated the content of lysoplasmalogens, including plasmatic lysophosphatidylethanolamine 18:0 (LPE P-18:0) and adipocyte-specific Tmem86a knockout (AKO) increases LPE P-18:0 content in adipose tissue. LPE P-18:0 could reduce the activity of PDE3B (phosphodiesterase 3b), which is abundantly expressed in adipocytes and can degrade cAMP. Furthermore, LPE P18:0 treatment reduced body weight and fat mass, increased energy expenditure, and strongly activated the PKA signaling pathway in adipose tissue (35).

2.2.3 OVOL2 Ovo-like zinc finger 2 (OVOL2) belongs to the Ovo family of zinc-finger transcription factors family and is highly conserved in invertebrates and vertebrates (49). The C57BL/6J mice with Oval2 mutations induced by Nethyl-N-nitrosourea (ENU), named Oval2 boh/boh , were characterized by increased body weight without affecting food intake under a standard chow diet. The boh mutation is a single nucleotide transition from G to A, causing the substitution of tyrosine for a conserved cysteine, and does not affect the OVOL2 protein’s stability. Ovol2 knockout is embryonically lethal. The heterozygotes with the boh allele and the null allele of Ovol2 (Ovol2 boh/-) exhibited overall stronger phenotypes: obesity, reduced energy expenditure, and adipocyte thermogenesis. Overexpression of Ovol2 in adipocytes reduced total body and liver fat and improved insulin sensitivity in mice fed on a high-fat diet. Ovol2 is highly expressed in white adipose stromal cells but not in mature white adipocytes. OVOL2 can block adipogenesis by interacting with the C-terminal portion of C/ EBPa to inhibit its adipogenic function in both mouse and human adipocytes (34). The mechanism of OVOL2 in brown adipocytes remains elusive and needs more investigation.

2.3.2 SSU72 SSU72 is a dual-specific protein phosphatase and is expressed in a tissue-specific manner. Recent studies have demonstrated that SSU72 plays an important role in controlling the carboxyl-terminal domain (CTD) function of RNA polymerase II (RNAPII) and monitoring the liver (52–54). In adipose tissue, SSU72 phosphatase was highly enriched in brown adipose tissue relative to white adipose tissue.

04 frontiersin.org Nie et al. 10.3389/fendo.2023.1250487 comparing the transcriptome of human supraclavicular BAT (scBAT) and subcutaneous WAT and analyzing the transcriptome of the human multipotent adipose-derived stem (hMADS) cells differentiated into beige and white adipocytes, Gpr180 was found to be upregulated in brown fat on both tissue and cellular level. The knockdown of Gpr180 shifted brown and beige adipocytes towards a white-like phenotype. The whole body or inducible adipose tissue knockout of Gpr180 diminished brown and beige adipocyte function and impaired insulin resistance. The knockdown of Gpr180 did not affect cAMP levels and phosphorylation of PKA substrates. However, it reduced the phosphorylation of SMAD3 protein at serine 423 in the matured adipocyte. Besides, TGFb1-induced phosphorylation of SMAD3 and upregulation of Ucp1 were attenuated in beige adipocytes without GPR180, which indicates that GPR180 is required for full activation of the TGFb signaling machinery. Collagen triple helix repeat containing 1 (CTHRC1) was identified as GRP180’s potential ligand. Overexpression of Cthrc1 in male mice prevented body weight gain and increased energy expenditure during the HFDinduced weight gain. In sum, GPR180 and CTHRC1 are the components of the TGFb signaling pathway for adipocyte thermogenesis. These components regulate low-grade SMAD3 phosphorylation and control thermogenic adipocyte function, whole-body energy, and glucose homeostasis (38).

Ssu72 mRNA and protein levels were increased significantly in BAT and WAT after cold exposure. BAT from adipose-specific Ssu72 knockout mice appeared pale and showed enlarged mitochondria and disorganized cristae structures compared to WT mice. The knockout mice were much more cold-sensitive and intolerant after cold exposure. The expression of thermogenic genes and fatty acid boxidation genes was significantly attenuated in the brown adipose tissue of AKO mice. When endoplasmic reticulum (ER) homeostasis is disrupted, PKRlike ER-regulated kinase (PERK) is activated to phosphorylate the a subunit of eukaryotic initiation factor 2 (eIF2a) at serine 51 (Ser51). EIF2a phosphorylation represses most of the proteins’ translation to reduce ER stress. Dephosphorylation of eIF2a by its phosphatase GADD34 in the liver can improve insulin sensitivity and reduce hepatosteatosis in mice fed high-fat diets. By RNA-Seq analysis, most PERK-eIF2a target genes were significantly upregulated in AKO BAT. Mechanistically, SSU72 can directly interact with eIF2a to inhibit its phosphorylation and increase the protein translation of mitochondrial oxidative phosphorylation and adipocyte thermogenesis in BAT. Furthermore, metabolic dysfunction in Ssu72-abated BAT could return to almost normal after restoring Ssu72 expression (36).

2.3.3 CUL2-APPBP2 PR domain-containing 16 (PRDM16) is a master gene that controls the biogenesis of brown and beige adipocytes by forming a complex with transcriptional and epigenetic factors (12, 13, 15). PRDM16 is dynamically regulated at the post-translational level. Overexpression of euchromatic histone-lysine N-methyltransferase 1 (EHMT1) or chronic treatment with synthetic ligands of peroxisome proliferator-activated receptor-g (PPARg) prolongs PRDM16 protein’s half-life (55, 56). CUL2–APPBP2 complex as the ubiquitin E3 ligase was identified to determine PRDM16 protein stability by catalyzing its polyubiquitination. CUL2 functions as a scaffold protein by interacting with an E2 enzyme, elongation B (ELOB), elongation C (ELOC), and APPBP2 substrate receptor, also found in RING E3 ligase complexes (57, 58). Cul2 depletion in white adipocytes extended the half-life of PRDM16 protein and significantly increased uncoupled cellular respiration. Overexpression of Cul2 in adipocytes reduced brown/ beige-fat-selective genes’ expression. Consistent with the results of Cul2 deletion, deletion of Appbp2 also led to higher PRDM16 protein levels and increased expression of brown/beige-fat-selective genes compared with the control cells. APPBP2 (S561N) variant, associated with lower levels of 2 h postprandial serum glucose and insulin, weakly interacted with PRDM16 protein relative to WT APPBP2. Differentiated primary adipocytes from Appbp2 mutant mice expressed higher thermogenic gene levels than WT adipocytes. Besides, adipose-specific Cul2 or Appbp2 knockout mice expressed higher levels of PRDM16 protein and adipose thermogenesis, displayed significantly higher whole-body energy expenditure, and gained less body weight than controls (37).

2.4.2 NCC Circulating IL18 level is associated with body weight, insulin resistance, and metabolic syndrome in humans and mice (60). Il18 ablation in mice led to hyperphagia, obesity, insulin resistance, and decreased energy expenditure. Whole-body deletion of Il18r increased body weight and decreased energy expenditure, but white adipocyte browning was enhanced in mice on a chow diet (61, 62). This can be explained by the NaCl co-transporter (NCC) acting as an alternative receptor for IL18’s differential function in adipocyte thermogenesis. A single knockout of Ncc or a combined knockout of Il18r and Ncc, but not a single knockout of Il18r, blocked adipocyte thermogenesis. Consistent with this, brown adipocytes from Ncc−/− and Il18r −/− Ncc−/− mice, but not those from Il18r −/− mice, showed decreased levels of IL18 and induced uncoupled respiration. Furthermore, Ncc fi/fi Ucp1Cre mice gained more body weight, had lower adipocyte thermogenesis, and showed worse glucose intolerance and insulin resistance on high-fat diets. There is no difference in UCP1 positive areas and thermogenic genes’ expression in adipose tissue between Il18rfi/fi Ucp1Cre mice and control mice. However, the concise mechanism of IL18 for Ucp1 promotion is still unclear. It is only known that it is not dependent on the cAMP signaling pathway in brown adipocytes. Overall, IL18 uses NCC to promote thermogenesis in BAT but uses IL18R to enhance glucose sensitivity in WAT (39).

The transforming growth factor b (TGFb) signaling pathway is complex and associated with various human pathologies (59). By

The mitochondrial cristae biogenesis protein optic atrophy 1 (OPA1) was significantly downregulated in the human Frontiers in Endocrinology 05 frontiersin.org Nie et al. 10.3389/fendo.2023.1250487

uncoupled respiration and energy expenditure when activated by NE. The mice carrying the enforcedly assembled thermo porter gained less body weight, more glucose and insulin tolerance, and increased animal energy expenditure; the opposite metabolic phenotypes were observed in Mcu BKO and Emre BKO mice (41).

subcutaneous adipose tissue (SAT) of heavy co-twins by gene expression analysis and correlated with mitochondrial gene expres sion. O p a1 t g mice with ubiquitou s mild Opa1 overexpression were slightly resistant to high-fat diet-induced obesity, glucose intolerance, and hepatic steatosis compared to their littermate controls. Similarly, resistance to obesity was observed in a mouse model of Opa1 haploinsufficiency (63). Opa1 tg mice produce more heat at room temperature by promoting BAT function and WAT browning. Opa1 facilitates cell-autonomous adipocyte browning by upregulating Kdm3a, a member of the Jumanji demethylase. This increases brown and beige thermogenic activity by controlling the H3K9 methylation status of Adrb1 and Ucp1 (64, 65). Metabolomic profiling further revealed that fumarate levels produced from the urea cycle derived Kdm3a-dependent Ucp1 induction in adipocytes. Moreover, overexpression of Opa1 can increase cAMP contents to activate CREB to upregulate the rate-limiting urea cycle enzyme Cps1 (carbamoyl phosphate synthetase-1) in adipose tissue (40). Although OPA1 may not depend on its pro-mitochondrial fusion role, more research is needed to determine the mechanism by which it activates CREB.

2.5.3 Cysteine 253 to alanine (UCP1 C253A) Because UCP1 loss causes the depletion of most components of the mitochondrial electron transport chain (ETC) in BAT, the interpretation of phenotypes of Ucp1 KO mice is bewildering and confusing (72). Thermogenic reactive oxygen species (ROS) could reversibly modify a regulatory site (C253) on UCP1 to elevate UCP1-dependent respiration (67). Based on these findings, a mouse model in which the regulatory C253 site on UCP1 is mutated to an alanine (UCP1 C253A mouse) was generated to examine its role in regulating energy homeostasis and metabolic disease. Quantitative proteomics of BAT from WT, UCP1 KO, and UCP1 C253A mice demonstrated that BAT from UCP1 C253A mice maintained expression of the full mitochondrial metabolic proteins. Both male and female UCP1 C253A mice exhibited significantly lower VO2 consumption, energy expenditure, and VCO2 production in response to cold exposure. Fed on a high-fat, high-sucrose (HFHS) diet, male, and female WT and UCP1 C253A mice gained indistinguishable body weight, and their food intake was identical. Remarkably, male but not female C253A mice exhibited more glucose intolerance than WT mice. The proteomic analysis of adipose tissues from both male and female mice on HFHS diets suggested that UCP1 C253A strongly agonizes WAT inflammation in male but not female mice. The mutation of UCP1 C253A increased mitochondrial protein oxidation and systemic inflammation in male mice since the inflammatory cytokine expression was attenuated upon the supplementation of MitoQ (73), a mitochondria-targeted antioxidant. UCP1 C253A male mice treated with b-estradiol showed the decreased expression of inflammatory cytokines, which were significantly increased in BAT of untreated C253A mice (42).

2.5.2 MCU and EMRE By dissipating energy as heat, UCP1 mediates adaptive thermogenesis. Long-chain fatty acids bind on UCP1 to drive proton leak, while purine nucleotides bind on UCP1 to block this uncoupling process (66, 67). Sulfenylation of UCP1 on Cys253 is essential for acute cold-induced uncoupled respiration, while the lysine succinylation of UCP1 reduces its activity and stability (68). Cytosolic calcium can directly stimulate adenylyl cyclase activity to increase cAMP production and PKA activation to induce thermogenesis (69). Two endoplasmic reticulum-located calcium channels, sarco/endoplasmic reticulum Ca 2 + -ATPase 2b (SERCA2b) and ryanodine receptor 2 (RyR2), are involved in ATP-dependent and UCP1-independent calcium cycling machinery to dissipate energy as heat in a beige adipocyte (70). The mitochondrial calcium uniporter (MCU) complex, which consists of a pore-forming subunit (MCU) and several regulatory subunits, including essential MCU regulator (EMRE) and mitochondrial calcium uptake 1 (MICU1) et al., is a key regulator of mitochondrial calcium (71). Mcu BKO (Mcuf/f with Ucp1Cre mice) and Emre BKO (AAV-Emre gRNA into BAT of Rosa26-LSL-Cas9 with AdipoqCre) mice are hypothermic. They could not maintain their core body temperatures when challenged with cold exposure. Upon adrenergic stimulation, MCU recruits UCP1 through EMRE to form an MCU-EMRE-UCP1 complex (thermo porter), which increases mitochondrial calcium uptake to accelerate the tricarboxylic acid cycle and supply more protons that promote uncoupled respiration. A mutant EMCU (unable to conduct Ca2+) could interact with UCP1 at a similar level as the WT EMCU, decreasing the level of UCP1dependent respiration. MICU1 is the gatekeeper to prevent Ca2+ overload in mitochondria by interacting with MCU. Their interaction markedly decreased upon cold exposure or NE/CL316,243 treatment. AAV-Micu1 BKO (AAV-Micu1 gRNA into Rosa26-LSL-Cas9 with Adipoq-Cre) enhanced brown adipocyte

3 Factors on the adipose tissue microenvironment 3.1 COVID-19 COVID-19 caused patients adipose atrophy, weight loss, and cachexia by activating adipocyte thermogenesis. A transgenic mouse (ACE2Tg) that knocked in human angiotensin-converting enzyme 2 (ACE2) demonstrated progressive weight loss alongside ‘wild-type’ SARS-CoV-2 virus infection. SARS-CoV-2 infection augments adipose thermogenesis and increases thermogenic genes’ expression and UCP1 positive cells by histological and immunohistochemical analysis in BAT, sWAT (subcutaneous WAT) and vWAT (visceral WAT). SARS-CoV-2-infected adipose tissues suffered from hypoxia with high HIF1a expression and contained high levels of VEGF, a main target of HIF1a (74, 75). VEGF is a crucial angiogenic factor that augments adipose tissue browning (76, 77). Anti-VEGF mouse neutralizing antibody largely

increase the protein translation of adipocyte thermogenesis in BAT. Otherwise, the knockdown or knockout of PERK was not tested to examine whether it can promote or inhibit adipocyte thermogenesis in this study. ISR (Integrated stress response) pathway, including PERK, PKR, HRI, and GCN2 is also known to regulate phosphorylation of eIF2a (82), so there are still more studies needed to investigate the regulation of eIF2a phosphorylation in adipocyte thermogenesis. UCP1 protein is always regarded as an independent uncoupling protein to dissipate proton motive force without producing ATP, a new role of UCP1 in adipocyte thermogenesis has been expanded so that it can form a MCU-EMRE-UCP1 complex to increase mitochondrial calcium uptake to accelerate the tricarboxylic acid cycle and supply more protons that promote uncoupled respiration. It was previously reported that SERCA2b and RYR2 in the endoplasmic reticulum promote UCP1-independent adipocyte thermogenesis by regulating ATP-dependent calcium cycling machinery in beige adipocytes (70). This recent work revealed how Ca2+ regulates adipocyte thermogenesis in mitochondria and found that UCP1 can interact with other proteins to exert its effect. Investigating whether more proteins can interact with UCP1 to play roles in adipocyte thermogenesis is intriguing. Oval2 is reported to promote white adipogenesis and regulate beige and brown adipocyte thermogenesis. It’s unknown whether this gene would affect beige or brown adipogenesis since they all share a similar adipogenic mechanism depending on the activation of PPARg (83). In addition, there is also an alternative way to promote adipocyte thermogenesis by increasing sympathetic innervation in adipose tissue. COVID-19 infection promoted the angiogenesis of adipose tissue and Zn stimulated the length of primary sympathetic neurons’ neurite outgrowth so that more adipocytes could be innervated for adipose thermogenesis. Although the research works mentioned here are novel and interesting, most of them are firstly reported here and based on a single study from a single research group. We consider that it will be more compelling and reliable if these results could be repeated by other research groups. Moreover, studies including more experimental repetitions are needed, in order to confirm that these genes are also effective in human adipocyte thermogenesis. In Table 1, we listed research works that include human studies. These research works have just tested the expression levels or functions of these relevant genes, using experiments performed either in vitro or in adipose tissue from healthy and obese human patients. However, they did not include sufficient data to support their associations with human energy expenditure. As such, it is still necessary to demonstrate that these genes are able to in vivo regulate human energy expenditure. It is intriguing to combat human metabolic disorders and obesity by targeting adipocyte thermogenesis. In humans, mild cold exposure, which can activate adrenergic receptor signaling pathways, could increase the rates of glucose, fatty acid uptake, and oxidative metabolism in the brown adipose tissue (84, 85). Moreover, the oral administration of mirabegron (a human b3 adrenergic receptor agonist approved for overactive bladder treatment), could activate human brown adipose tissue and increase whole-body energy expenditure (86, 87). Furthermore, a retrospective cohort study concluded that humans with positive BAT had a healthier body fat distribution, with a decreased visceral

restored the sWAT and vWAT mass relative to the non-immune IgG (NIIgG)-treated sWAT and vWAT. As seen in mouse models, browning phenotypes of adipose tissues were also observed in SARS-CoV-2-infected Syrian hamsters and human patients who died of severe COVID-19 (43).

3.2 Zn Zn is one of life’s most important essential trace elements and has been associated with insulin resistance and adiposity (78). The low level of plasma Zn is associated with obesity. Its supplementation significantly reduces body weight and plasma cholesterol and triglycerides (79, 80). Cold induces sympathetic innervation, which promotes UCP1 expression and Zn secretion from thermogenic adipocytes. However, Zn did not directly influence thermogenic genes’ expression in primary beige adipocytes. Zn stimulated the length of primary sympathetic neurons’ neurite outgrowth to contribute to thermogenesis. Zn injection induced sympathetic innervation in scWAT and BAT. On the contrary, local injection of Zn chelator TPEN in scWAT and BAT caused a decrease in sympathetic innervation. Furthermore, 6-hydroxidopamine (6-OHDA), which locally ablates sympathetic fibers in BAT and scWAT of Zn-treated HFD mice, blocked the anti-obesity effect of Zn treatment. MT2, cysteine-rich proteins that bind to Zn with high affinity, in scWAT and BAT are upregulated by high-fat diets. MT2 expression is increased in human scWAT samples from obese individuals and positively correlated with body mass index (BMI). Adipose tissue-specific Mt2 knockout increased VO2, thermogenic genes’ expression, and UCP1 protein levels in scWAT and BAT. At the same time Mt2 overexpression in BAT and scWAT resulted in decreased sympathetic innervation, VO2, and thermogenic gene expression without changes in body weight (44).

4 Discussion Adipocyte thermogenesis is regulated by complex transcriptional factors like PRDM16, PPARg, EBF2, ect, and has been studied extensively (8, 81). Recently, Emc10, Tmem86a, Hif2a, and Adissp have been reported to be involved in adipocyte thermogenesis by regulating the PKA-CREB signaling pathway. This pathway is mainly activated by cold exposure or beta-adrenergic agonists and has been proven to be the most effective way to activate adipocyte thermogenesis. Secreted EMC10 can interact with the Protein Kinase A catalytic subunit a to inhibit it from phosphorylating CREB, HIF2a negatively regulated the expression of Prkaca. In contrast, TMEM86A blocked the activation of PKA by reducing the level of cAMP. Conversely, OPA1 can increase cAMP contents to activate the PKA-CREB pathway. In addition, the PKA signaling pathway can be directly activated by ADISSP, but its concise molecular mechanism was not clarified. Thus, regulating the PKACREB pathway in adipocyte thermogenesis could still be an important research area. Upon ER stress, PERK is activated to increase eIF2a phosphorylation to repress most of the proteins’ translation. SSU72 can directly interact with eIF2a to inhibit its phosphorylation and

Foundation of Guangdong province (2022A1515010283), initial funding from Hubei University of Arts and Science (2059200), and Pearl River S&T Nova Program of Guangzhou (201806010166).

adipose tissue content and an increased subcutaneous adipose tissue content, as well as improved metabolic symptoms, such as lower blood glucose and lipids, and decreased liver fat accumulation (88). Moreover, another independent retrospective cohort study has also reported an association of human positive BAT with improved cardiometabolic health in terms of dyslipidemia, coronary artery disease, congestive heart failure, and hypertension, especially in overweight or obese individuals (89). However, progress in combating obesity by targeting human thermogenic adipocyte tissue is relatively slow due to issues including ethical reasons. Nevertheless, extensive rodent research has demonstrated the feasibility of combating obesity by targeting thermogenic adipose tissues (90, 91). In sum, though most of these recent findings have been analyzed or verified in human adipocytes or adipose tissue, it is still a long and arduous way to transform these basic studies into a clinic.

Acknowledgment The authors would like to thank all the reviewers who participated in the review and EditSpring for its linguistic assistance during the preparation of this manuscript.

Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Author contributions TN, HZ, and LM wrote and revised the manuscript. JL revised the manuscript. All authors contributed to the article and approved the submitted version.

Publisher’s note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

📖 中文全文 Chinese Full Text

中文

# 脂肪细胞产热调控基因的最新进展

**聂涛¹*,卢金丽²,张华³*,毛柳凤²¹**

¹ 湖北文理学院基础医学院,中国襄阳;² 广东药科大学附属第一医院科研中心,中国广州;³ 广州医科大学第二附属医院医学影像科,中国广州

## 摘要

能量失衡会导致肥胖:能量摄入过多或能量消耗过少,或两者兼有。肥胖可能是许多代谢性疾病的根源,如2型糖尿病和心血管疾病。UCP1(解偶联蛋白1)在产热脂肪细胞(包括米色脂肪细胞和棕色脂肪细胞)中高度且特异性表达,能将质子驱动力转化为热量而不产生ATP,从而增加能量消耗。通过增强非颤抖性脂肪细胞产热来对抗肥胖及其相关代谢疾病是一种有前景的策略。近年来,多个新基因被报道参与脂肪细胞产热的调控。本文总结了脂肪细胞产热调控领域的最新研究进展,为该领域提供了新的潜在治疗靶点。

**关键词:** 肥胖,脂肪细胞产热,肾上腺素能信号通路,PKA,UCP1

## 1 引言

肥胖在全球范围内日益流行,对人类健康构成巨大威胁(1)。能量失衡导致肥胖:能量摄入过多或能量消耗过少,或两者兼有。因此,通过减少能量摄入或增加能量消耗来预防和治疗肥胖是有效的。GLP-1已通过减少能量摄入在临床上有效用于治疗肥胖(2, 3)。近年来,大量研究表明,非颤抖性脂肪细胞产热(通常用于维持体温)可以被促进以增加能量消耗并抵抗肥胖。激活产热脂肪细胞是对抗肥胖的有前景的策略(4, 5)。

脂肪组织传统上分为白色脂肪组织(WAT)和棕色脂肪组织(BAT)。形态学上,白色脂肪细胞具有独特的大脂滴,而棕色脂肪细胞具有许多小脂滴和更多功能性线粒体(6)。功能上,白色脂肪细胞储存能量并分泌多种细胞因子,包括脂联素和瘦素等,以调节代谢(7);棕色脂肪细胞高表达线粒体内膜蛋白UCP1(解偶联蛋白1),能将质子驱动力转化为热量而不产生ATP。在寒冷或药理学条件下,白色脂肪组织中会诱导产生一种棕色样脂肪细胞,称为米色脂肪细胞或brite脂肪细胞(8)。与棕色脂肪细胞类似,米色脂肪细胞具有许多小脂滴并高表达UCP1以产生热量;棕色和米色脂肪细胞也被称为产热脂肪细胞(图1)。棕色和米色脂肪细胞功能相同,但起源不同。米色和白色脂肪细胞大多为Myf5阴性(9-11),而棕色脂肪细胞为Myf5阳性,与肌细胞共享前体细胞(12)。Prdm16是棕色和米色脂肪细胞身份的主控基因。在成肌细胞中过表达Prdm16可使其转分化为棕色脂肪细胞(13, 14),而在白色脂肪组织中敲除Prdm16则消除了寒冷对米色脂肪细胞的诱导作用(15, 16)。

有趣的是,当白色脂肪组织中的β-肾上腺素能信号通路被消除时,一种糖酵解型米色脂肪细胞从Myf5阳性前体细胞中被诱导产生(17)。棕色脂肪组织位于哺乳动物的肩胛间区,白色脂肪组织主要位于皮下和内脏区(6)。值得注意的是,棕色脂肪组织在人类成长过程中逐渐消失(18, 19)。人类颈部深层存在棕色和米色脂肪细胞(20, 21)。此外,米色和棕色脂肪细胞与体重呈正相关(22, 23)。

寒冷刺激是激活脂肪细胞产热最有效的方式。寒冷暴露时,脂肪组织受交感神经支配。分泌的去甲肾上腺素与脂肪细胞上的β-肾上腺素能受体结合,激活Gs信号通路和腺苷酸环化酶,从而提高环磷酸腺苷(cAMP)含量。随后,cAMP与蛋白激酶A(PKA)的调节亚基结合,激活其催化亚基C,使下游转录因子CREB磷酸化。磷酸化的CREB蛋白进入细胞核,上调包括Ucp1在内的产热基因表达(24-27)。

许多研究表明,多种细胞因子、转录因子、激酶和膜受体(如FGF21、IRF4和ZFP516等)参与脂肪细胞产热的调控(28-31)。本文总结了脂肪细胞产热调控领域的最新研究(见表1和图2)。

## 2 直接作用于脂肪细胞的因素

### 2.1 分泌蛋白

#### 2.1.1 EMC10

由于差异剪接,内质网膜复合物亚基10存在两种亚型:膜结合型EMC10和分泌型EMC10(scEMC10)(45, 46)。在中国汉族人群中,scEMC10血清水平与肥胖和胰岛素抵抗呈正相关。减肥手术或运动及热量限制后,血清scEMC10水平下降。全身性Emc10敲除小鼠表现出更强的脂肪细胞产热和更高的全身能量消耗,能够抵抗高脂饮食诱导的肥胖和胰岛素抵抗。相反,Emc10过表达小鼠在高脂饮食下更容易发生肥胖和胰岛素抵抗,脂肪细胞产热减少,全身能量消耗降低。此外,针对EMC10的循环中和抗体也有助于小鼠减少体重增长。机制上,分泌型EMC10可被脂肪细胞摄取,与蛋白激酶A催化亚基α相互作用,抑制其对CREB的磷酸化。因此,磷酸化CREB蛋白减少导致脂肪细胞产热降低(47)。

#### 2.1.2 ADISSP

ADISSP(脂肪分泌信号蛋白)是一种新的未表征脂肪因子,在人和小鼠棕色脂肪组织中高度选择性表达。该蛋白在正常人群脂肪组织中的表达高于肥胖人群,与体重指数呈负相关。通过Ap2启动子在脂肪组织中过表达Adissp可促进脂肪细胞产热,增强氧消耗,增加糖酵解,升高体温,并抵抗高脂饮食诱导的体重增长。相反,脂肪特异性Adissp敲除小鼠体温较低,脂肪细胞产热减少,更容易发生高脂饮食诱导的肥胖和高血糖。ADISSP通过旁分泌信号而非内分泌信号促进白色脂肪细胞棕色化和棕色脂肪细胞活性。目前缺乏更灵敏的方法来测量ADISSP内源性循环水平。PKA信号通路可被ADISSP独立于β-肾上腺素能信号通路而激活(32)。尽管脂肪细胞表面存在与ADISSP结合的受体,但该受体基因尚未确认。

### 2.2 转录因子

#### 2.2.1 HIFα

HIFα(缺氧诱导因子α)有两个家族成员:HIF1α和HIF2α(48)。寒冷暴露后,这两个基因在白色和棕色脂肪组织中均上调表达。寒冷暴露或CL316243(β-肾上腺素能激动剂)刺激下,脂肪组织Hif1α或Hif2α或双基因敲除小鼠与野生型小鼠相比,腹股沟脂肪组织中米色脂肪细胞更多,能量消耗更高。通过RNA-Seq分析,编码PKA催化亚基α(PKA Ca)的Prkaca基因在Hif2a敲除小鼠脂肪组织中排名靠前。通过计算机分析,发现miR-3085-3p(受HIF2α直接调控)靶向Prkaca 3'UTR的进化保守区域。因此,脂肪细胞HIF2α可通过促进miR-3085-3p表达来抑制PKA Ca介导的产热特性(33)。

#### 2.2.2 OVOL2

Ovo样锌指蛋白2(OVOL2)属于Ovo锌指转录因子家族,在无脊椎动物和脊椎动物中高度保守(49)。通过N-乙基-N-亚硝基脲(ENU)诱导Ovol2突变的C57BL/6J小鼠(命名为Ovol2^boh/boh^)在标准饮食下表现为体重增加但食物摄入量不受影响。boh突变是G到A的单核苷酸转换,导致保守半胱氨酸被酪氨酸取代,不影响OVOL2蛋白的稳定性。Ovol2敲除具有胚胎致死性。携带boh等位基因和Ovol2无效等位基因的杂合子(Ovol2^boh/-^)表现出更强的表型:肥胖、能量消耗和脂肪细胞产热减少。在脂肪细胞中过表达Ovol2可减少高脂饮食小鼠的总脂肪和肝脏脂肪,并改善胰岛素敏感性。OVOL2在白色脂肪基质细胞中高表达,但在成熟白色脂肪细胞中不表达。OVOL2可通过与C/EBPα的C末端部分相互作用来阻断成脂作用,抑制其在小鼠和人脂肪细胞中的成脂功能(34)。OVOL2在棕色脂肪细胞中的作用机制仍不清楚,需要进一步研究。

### 2.3 酶

#### 2.3.1 TMEM86A

跨膜蛋白86A(TMEM86A)是一种推定的溶血缩醛磷脂酶,是TMEM86B的同源物,也是YhhN家族蛋白成员(50, 51)。与高脂饮食相比,标准饮食下脂肪组织中Tmem86a表达显著上调,并在成熟脂肪细胞中大量富集。转录组分析(GEO: GSE94753)也显示,肥胖女性患者腹部皮下白色脂肪组织中TMEM86A表达上调。脂肪组织特异性Tmem86a敲除小鼠的线粒体代谢、脂肪细胞产热和能量消耗增加,体重增长显著降低。机制上,非靶向脂质组学分析表明,Tmem86a过表达下调缩醛磷脂(包括缩醛磷脂酰乙醇胺18:0(LPE P-18:0))的含量,而脂肪特异性Tmem86a敲除(AKO)增加脂肪组织中LPE P-18:0含量。LPE P-18:0可降低PDE3B(磷酸二酯酶3b)的活性,PDE3B在脂肪细胞中大量表达,可降解cAMP。此外,LPE P-18:0处理可减少体重和脂肪量,增加能量消耗,并强烈激活脂肪组织中的PKA信号通路(35)。

#### 2.3.2 SSU72

SSU72是一种双特异性蛋白磷酸酶,以组织特异性方式表达。近期研究表明,SSU72在控制RNA聚合酶II(RNAPII)的羧基末端结构域(CTD)功能和监测肝脏功能中发挥重要作用(52-54)。在脂肪组织中,SSU72磷酸酶在棕色脂肪组织中相对于白色脂肪组织高度富集。寒冷暴露后,BAT和WAT中Ssu72 mRNA和蛋白水平显著升高。脂肪特异性Ssu72敲除小鼠的BAT呈苍白状态,与WT小鼠相比,线粒体增大且嵴结构紊乱。敲除小鼠对寒冷更加敏感和耐受不良。AKO小鼠棕色脂肪组织中产热基因和脂肪酸β-氧化基因表达显著减弱。

当内质网(ER)稳态被破坏时,PKR样ER调节激酶(PERK)被激活,使真核起始因子2(eIF2a)的α亚基在丝氨酸51(Ser51)位点磷酸化。eIF2a磷酸化抑制大多数蛋白质的翻译以减轻ER应激。在肝脏中,eIF2a磷酸酶GADD34对eIF2a的去磷酸化可改善高脂饮食小鼠的胰岛素敏感性并减少肝脂肪变性。通过RNA-Seq分析,大多数PERK-eIF2a靶基因在AKO BAT中显著上调。机制上,SSU72可直接与eIF2a相互作用,抑制其磷酸化,并增加BAT中线粒体氧化磷酸化和脂肪细胞产热的蛋白质翻译。此外,恢复Ssu72表达后,Ssu72缺失BAT的代谢功能可几乎恢复正常(36)。

#### 2.3.3 CUL2-APPBP2

PR结构域包含蛋白16(PRDM16)是控制棕色和米色脂肪细胞生物发生的主控基因,通过与转录和表观遗传因子形成复合物发挥作用(12, 13, 15)。PRDM16在翻译后水平受到动态调控。常染色质组蛋白-赖氨酸N-甲基转移酶1(EHMT1)的过表达或过氧化物酶体增殖物激活受体γ(PPARγ)合成配体的慢性处理可延长PRDM16蛋白的半衰期(55, 56)。CUL2-APPBP2复合物作为泛素E3连接酶,通过催化PRDM16的多泛素化来决定其蛋白稳定性。CUL2作为支架蛋白,与E2酶延伸蛋白B(ELOB)、延伸蛋白C(ELOC)和APPBP2底物受体相互作用,也存在于RINGE3连接酶复合物中(57, 58)。白色脂肪细胞中Cul2缺失可延长PRDM16蛋白的半衰期,并显著增加细胞解偶联呼吸。在脂肪细胞中过表达Cul2可降低棕色/米色脂肪选择性基因的表达。与Cul2缺失结果一致,Appbp2的缺失也导致PRDM16蛋白水平升高和棕色/米色脂肪选择性基因表达增加。APPBP2(S561N)变体与餐后2小时血清葡萄糖和胰岛素水平降低相关,与WT APPBP2相比,与PRDM16蛋白的相互作用较弱。来自Appbp2突变小鼠的分化原代脂肪细胞比WT脂肪细胞表达更高水平的产热基因。此外,脂肪特异性Cul2或Appbp2敲除小鼠表达更高水平的PRDM16蛋白和脂肪产热,表现出显著更高的全身能量消耗,体重增长少于对照组(37)。

### 2.4 其他膜蛋白

#### 2.4.1 GPR180

转化生长因子β(TGFβ)信号通路复杂,与人类多种病理状态相关(59)。通过比较人类锁骨上BAT(scBAT)和皮下WAT的转录组,以及分析人类多能脂肪来源干细胞(hMADS)分化为米色和白色脂肪细胞的转录组,发现Gpr180在组织和细胞水平的棕色脂肪中均上调表达。GPR180的敲低使棕色和米色脂肪细胞向白色样表型转变。GPR180的全身性或诱导性脂肪组织敲低会削弱棕色和米色脂肪细胞功能并损害胰岛素抵抗。GPR180的敲低不影响cAMP水平和PKA底物的磷酸化。然而,它降低了成熟脂肪细胞中SMAD3蛋白在丝氨酸423位点的磷酸化。此外,在没有GPR180的米色脂肪细胞中,TGFβ1诱导的SMAD3磷酸化和Ucp1上调被减弱,这表明GPR180是TGFβ信号机器完全激活所必需的。胶原蛋白三螺旋重复序列包含蛋白1(CTHRC1)被鉴定为GPR180的潜在配体。在雄性小鼠中过表达Cthrc1可防止体重增加,并在HFD诱导的体重增长期间增加能量消耗。总之,GPR180和CTHRC1是脂肪细胞产热TGFβ信号通路的组成部分。这些组分调节低水平SMAD3磷酸化并控制产热脂肪细胞功能、全身能量和葡萄糖稳态(38)。

#### 2.4.2 NCC

循环IL18水平与人类和小鼠的体重、胰岛素抵抗和代谢综合征相关(60)。小鼠Il18缺失导致多食、肥胖、胰岛素抵抗和能量消耗降低。Il18r的全身缺失增加体重并降低能量消耗,但在饮食小鼠中白色脂肪细胞棕色化增强(61, 62)。这可以通过NaCl协同转运蛋白(NCC)作为IL18在脂肪细胞产热中差异功能的替代受体来解释。Ncc的单基因敲除或Il18r和Ncc的联合敲除(而非Il18r的单基因敲除)可阻断脂肪细胞产热。与此一致,来自Ncc^-/-^和Il18r^-/-^Ncc^-/-^小鼠(而非Il18r^-/-^小鼠)的棕色脂肪细胞显示IL18水平和诱导解偶联呼吸降低。此外,Ncc^fl/fl^Ucp1Cre小鼠在高脂饮食下体重增加更多,脂肪细胞产热降低,葡萄糖耐受不良和胰岛素抵抗更严重。Il18r^fl/fl^Ucp1Cre小鼠与对照组小鼠之间脂肪组织中UCP1阳性区域和产热基因表达无差异。然而,IL18促进Ucp1的确切机制仍不清楚。目前已知它不依赖于棕色脂肪细胞中的cAMP信号通路。总体而言,IL18利用NCC促进BAT中的产热,但利用IL18R增强WAT中的葡萄糖敏感性(39)。

### 2.5 线粒体相关蛋白

#### 2.5.1 OPA1

通过基因表达分析,线粒体嵴生物发生蛋白视神经萎缩蛋白1(OPA1)在重度同卵双胞胎的人皮下脂肪组织(SAT)中显著下调,并与线粒体基因表达相关。具有普遍性轻度OPA1过表达的Opa1^tg^小鼠与同窝对照相比,对高脂饮食诱导的肥胖、葡萄糖耐受不良和肝脂肪变性具有轻微抗性。类似地,在OPA1单倍体不足的小鼠模型中也观察到对肥胖的抗性(63)。Opa1^tg^小鼠通过促进BAT功能和WAT棕色化在室温下产生更多热量。Opa1通过上调Jumanji去甲基化酶家族成员Kdm3a来促进细胞自主性脂肪细胞棕色化。这通过控制Adrb1和Ucp1的H3K9甲基化状态来增加棕色和米色产热活性(64, 65)。代谢组学分析进一步揭示,尿素循环衍生的富马酸水平参与Kdm3a依赖性的脂肪细胞Ucp1诱导。此外,Opa1的过表达可增加cAMP含量以激活CREB,上调脂肪组织中限速尿素循环酶Cps1(氨甲酰磷酸合成酶-1)的表达(40)。尽管OPA1可能不依赖于其促线粒体融合功能,但需要更多研究来确定其激活CREB的机制。

#### 2.5.2 MCU和EMRE

UCP1通过以热量形式散失能量来介导适应性产热。长链脂肪酸与UCP1结合以驱动质子泄漏,而嘌呤核苷酸与UCP1结合以阻断这一解偶联过程(66, 67)。UCP1在Cys253位点的亚磺酰化对急性寒冷诱导的解偶联呼吸至关重要,而UCP1的赖氨酸琥珀酰化则降低其活性和稳定性(68)。胞质钙可直接刺激腺苷酸环化酶活性以增加cAMP产生和PKA激活,从而诱导产热(69)。内质网上的两个钙通道——肌浆/内质网Ca²⁺-ATP酶2b(SERCA2b)和兰尼碱受体2(RyR2)——参与ATP依赖性和UCP1非依赖性的钙循环机制,在米色脂肪细胞中以热量形式散失能量(70)。

线粒体钙单向转运体(MCU)复合物由孔道形成亚基(MCU)和几个调节亚基组成,包括必需MCU调节蛋白(EMRE)和线粒体钙摄取蛋白1(MICU1)等,是线粒体钙的关键调节因子(71)。Mcu BKO(Mcu^f/f^与Ucp1Cre小鼠)和Emre BKO(AAV-Emre gRNA导入Rosa26-LSL-Cas9与AdipoqCre小鼠的BAT)小鼠表现为低体温。它们在寒冷暴露挑战时无法维持核心体温。在肾上腺素能刺激下,MCU通过EMRE招募UCP1形成MCU-EMRE-UCP1复合物(产热转运体),增加线粒体钙摄取以加速三羧酸循环,提供更多质子促进解偶联呼吸。突变型EMCU(不能传导Ca²⁺)可与UCP1以与WT EMCU相似的水平相互作用,降低UCP1依赖性呼吸水平。MICU1是防止线粒体Ca²⁺超载的守门蛋白,通过与MCU相互作用发挥作用。在寒冷暴露或NE/CL316,243处理下,它们的相互作用显著降低。AAV-Micu1 BKO(AAV-Micu1 gRNA导入Rosa26-LSL-Cas9与Adipoq-Cre小鼠)增强了棕色脂肪细胞的解偶联呼吸和能量消耗。携带强制组装产热转运体的小鼠体重增加更少,葡萄糖和胰岛素耐受性更强,动物能量消耗增加;在Mcu BKO和Emre BKO小鼠中观察到相反的代谢表型(41)。

#### 2.5.3 半胱氨酸253突变为丙氨酸(UCP1 C253A)

由于UCP1缺失导致BAT中线粒体电子传递链(ETC)大部分组分耗竭,Ucp1 KO小鼠的表型解释令人困惑(72)。产生活性氧(ROS)可逆性修饰UCP1上的调控位点(C253),以增强UCP1依赖性呼吸(67)。基于这些发现,构建了UCP1上调控性C253位点突变为丙氨酸的小鼠模型(UCP1 C253A小鼠),以研究其在调节能量稳态和代谢疾病中的作用。对WT、UCP1 KO和UCP1 C253A小鼠BAT的定量蛋白质组学分析表明,UCP1 C253A小鼠的BAT维持了完整线粒体代谢蛋白的表达。雄性和雌性UCP1 C253A小鼠在寒冷暴露下的VO₂消耗、能量消耗和VCO₂产生均显著降低。在高脂高糖(HFHS)饮食下,雄性和雌性WT和UCP1 C253A小鼠的体重增长和食物摄入量无显著差异。值得注意的是,雄性(而非雌性)C253A小鼠比WT小鼠表现出更严重的葡萄糖耐受不良。对HFHS饮食下雄性和雌性小鼠脂肪组织的蛋白质组学分析表明,UCP1 C253A在雄性(而非雌性)小鼠中强烈激动WAT炎症。UCP1 C253A突变增加了雄性小鼠的线粒体蛋白氧化和全身炎症,因为补充线粒体靶向抗氧化剂MitoQ后炎症因子表达减弱(73)。用β-雌二醇处理的UCP1 C253A雄性小鼠显示炎症因子表达降低,而在未处理的C253A小鼠BAT中这些因子显著增加(42)。

## 3 脂肪组织微环境因素

### 3.1 COVID-19

COVID-19通过激活脂肪细胞产热导致患者脂肪萎缩、体重减轻和恶病质。敲入人血管紧张素转换酶2(ACE2)的转基因小鼠(ACE2Tg)在感染野生型SARS-CoV-2病毒后表现出进行性体重减轻。SARS-CoV-2感染增强了脂肪产热,并通过BAT、sWAT(皮下WAT)和vWAT(内脏WAT)的组织学和免疫组织化学分析显示产热基因表达和UCP1阳性细胞增加。SARS-CoV-2感染的脂肪组织缺氧,HIF1α表达升高,VEGF(HIF1α的主要靶点)水平升高(74, 75)。VEGF是增强脂肪组织棕色化的关键血管生成因子(76, 77)。抗VEGF小鼠中和抗体在很大程度上恢复了sWAT和vWAT的质量。在叙利亚仓鼠和死于重症COVID-19的人类患者中也观察到脂肪组织的棕色化表型(43)。

### 3.2 Zn

Zn是生命中最重要的必需微量元素之一,与胰岛素抵抗和肥胖相关(78)。血浆Zn水平低与肥胖相关。补充Zn可显著降低体重、血浆胆固醇和甘油三酯(79, 80)。寒冷诱导交感神经支配,促进UCP1表达和产热脂肪细胞中Zn的分泌。然而,Zn不直接影响原代米色脂肪细胞中产热基因的表达。Zn刺激初级交感神经元神经突生长长度以促进产热。Zn注射诱导scWAT和BAT中的交感神经支配。相反,在scWAT和BAT中局部注射Zn螯合剂TPEN导致交感神经支配减少。此外,6-羟基多巴胺(6-OHDA)局部消融Zn处理HFD小鼠BAT和scWAT中的交感纤维,阻断了Zn处理的抗肥胖效果。高脂饮食上调scWAT和BAT中MT2(与Zn高亲和力结合的半胱氨酸丰富蛋白)的表达。肥胖个体人scWAT样本中MT2表达增加,与体重指数(BMI)呈正相关。脂肪特异性Mt2敲除增加scWAT和BAT中的VO₂、产热基因表达和UCP1蛋白水平。同时,BAT和scWAT中Mt2过表达导致交感神经支配、VO₂和产热基因表达降低,但体重无变化(44)。

## 4 讨论

脂肪细胞产热受PRDM16、PPARγ、EBF2等复杂转录因子的调控,已被广泛研究(8, 81)。近年来,Emc10、Tmem86a、Hif2a和Adissp被报道通过调节PKA-CREB信号通路参与脂肪细胞产热。该通路主要由寒冷暴露或β-肾上腺素能激动剂激活,已被证明是激活脂肪细胞产热最有效的方式。分泌型EMC10可与蛋白激酶A催化亚基α相互作用,抑制其对CREB的磷酸化;HIF2α负调控Prkaca的表达。相反,TMEM86A通过降低cAMP水平阻断PKA的激活。而OPA1可增加cAMP含量以激活PKA-CREB通路。此外,PKA信号通路可被ADISSP直接激活,但其确切分子机制尚未阐明。因此,调控脂肪细胞产热中的PKA-CREB通路仍是一个重要的研究领域。

在ER应激时,PERK被激活以增加eIF2a磷酸化,抑制大多数蛋白质的翻译。SSU72可直接与eIF2a相互作用,抑制其磷酸化并增加脂肪细胞产热的蛋白翻译。此外,本研究未测试PERK的敲低或敲除是否能促进或抑制脂肪细胞产热。ISR(整合应激反应)通路(包括PERK、PKR、HRI和GCN2)也已知调控eIF2a磷酸化(82),因此仍需更多研究来探讨脂肪细胞产热中eIF2a磷酸化的调控。

UCP1蛋白一直被视为独立的解偶联蛋白,在不产生ATP的情况下散失质子驱动力。脂肪细胞产热中UCP1的新作用已被扩展——它可形成MCU-EMRE-UCP1复合物以增加线粒体钙摄取,加速三羧酸循环,提供更多质子促进解偶联呼吸。此前有报道,内质网中的SERCA2b和RYR2通过调节米色脂肪细胞中ATP依赖性钙循环机制来促进UCP1非依赖性脂肪细胞产热(70)。这项最新研究揭示了Ca²⁺如何在线粒体中调节脂肪细胞产热,并发现UCP1可与其他蛋白质相互作用以发挥其效应。研究更多蛋白质是否能与UCP1相互作用以在脂肪细胞产热中发挥作用是一个有趣的课题。

Ovol2被报道促进白色脂肪生成并调节米色和棕色脂肪细胞产热。目前尚不清楚该基因是否会影响米色或棕色脂肪生成,因为它们都依赖于PPARγ激活的相似成脂机制(83)。此外,还有一种通过增加脂肪组织交感神经支配来促进脂肪细胞产热的替代方式。COVID-19感染促进了脂肪组织的血管生成,Zn刺激了初级交感神经元神经突的生长,从而使更多脂肪细胞受到神经支配以促进脂肪产热。

尽管此处提及的研究工作新颖且有趣,但大多数是首次报道,且来自单一研究团队的单一项研究。如果这些结果能被其他研究团队重复,将更具说服力和可靠性。此外,需要更多包含更多实验重复的研究,以证实这些基因在人脂肪细胞产热中也有效。在表1中,我们列出了包含人体研究的研究工作。这些研究仅通过体外实验或来自健康和肥胖人患者的脂肪组织检测了相关基因的表达水平或功能。然而,它们未包含足够的数据来支持与人能量消耗的关联。因此,仍有必要证明这些基因能够在体内调节人的能量消耗。

通过靶向脂肪细胞产热来对抗人类代谢疾病和肥胖是一个有前景的方向。在人类中,轻度寒冷暴露可激活肾上腺素能受体信号通路,增加棕色脂肪组织中葡萄糖、脂肪酸摄取和氧化代谢的速率(84, 85)。此外,口服米拉贝隆(一种被批准用于治疗膀胱过度活动的人类β3肾上腺素能受体激动剂)可激活人棕色脂肪组织并增加全身能量消耗(86, 87)。此外,一项回顾性队列研究表明,BAT阳性的人具有更健康的体脂分布,内脏脂肪减少。

## 致谢

本研究得到广东省自然科学基金(2022A1515010283)、湖北文理学院启动基金(2059200)和广州市珠江科技新星计划(201806010166)的资助。

体脂含量增加,皮下脂肪组织含量升高,同时代谢症状得到改善,例如血糖和血脂水平降低,肝脏脂肪堆积减少(88)。此外,另一项独立的回顾性队列研究也报告了人类棕色脂肪组织(BAT)阳性与心血管代谢健康改善之间的关联,具体表现在血脂异常、冠心病、充血性心力衰竭和高血压等方面,尤其是在超重或肥胖个体中更为显著(89)。然而,由于伦理等原因,通过靶向人类产热脂肪组织来对抗肥胖的进展相对缓慢。尽管如此,大量啮齿类动物研究已证实,靶向产热脂肪组织对抗肥胖具有可行性(90, 91)。总之,尽管这些近期发现大多已在人类脂肪细胞或脂肪组织中进行了分析或验证,但将这些基础研究转化为临床应用仍任重而道远。

致谢 作者感谢所有参与审稿的审稿人,并感谢EditSpring在稿件撰写过程中提供的语言协助。

利益冲突声明 作者声明,本研究是在不存在任何可能被解读为潜在利益冲突的商业或财务关系的情况下进行的。

作者贡献 TN、HZ和LM撰写并修改了稿件;JL对稿件进行了修改。所有作者均对本文有所贡献,并同意投稿版本。

出版方说明 本文所载主张仅代表作者本人观点,并不必然反映其所属机构、出版方、编辑或审稿人的立场。本文中提及的任何产品或其制造商的主张,均未经出版方认可或背书。